Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Akebia quinata extract (AQE) is a botanical extract derived from the *Akebia quinata* plant, a woody vine native to East Asia and used in traditional Korean and Chinese medicine. The extract contains a variety of bioactive compounds, including saponins (such as akequintoside D), triterpenoids (oleanolic acid, hederagenin), and phenolic acids (chlorogenic acid). AQE is primarily investigated for its anti-obesity and hypolipidemic properties, which are mediated through the activation of the AMP-activated protein kinase (AMPK) pathway. This activation leads to the inhibition of adipogenesis and the enhancement of fatty acid oxidation via the regulation of targets like acetyl-CoA carboxylase (ACC) and peroxisome proliferator-activated receptor alpha (PPARα). Additionally, the extract has demonstrated neuroprotective and anti-fatigue potential, possibly through the modulation of BDNF-TrkB signaling, and possesses antioxidant, analgesic, and diuretic activities.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on akebia quinata extract.